Invitrogen is acquiring Dynal Biotech from majority owner Nordic Capital and a co-investor for approximately NOK 2.5 billion.
WebProWorld
Invitrogen is acquiring Dynal Biotech from majority owner Nordic Capital and a co-investor for approximately NOK 2.5 billion.